MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $624,000 | -4.9% | 233,800 | -1.6% | 0.02% | -9.5% |
| Q3 2021 | $656,000 | -3.7% | 237,600 | -0.6% | 0.02% | -8.7% |
| Q2 2021 | $681,000 | +37.3% | 239,100 | +65.4% | 0.02% | +27.8% |
| Q1 2021 | $496,000 | +37.8% | 144,600 | +5.9% | 0.02% | +50.0% |
| Q4 2020 | $360,000 | -16.7% | 136,500 | -1.4% | 0.01% | -14.3% |
| Q3 2020 | $432,000 | -7.5% | 138,500 | +22.7% | 0.01% | +7.7% |
| Q2 2020 | $467,000 | +68.6% | 112,900 | -34.4% | 0.01% | +62.5% |
| Q1 2020 | $277,000 | -51.6% | 172,100 | -25.3% | 0.01% | -38.5% |
| Q4 2019 | $572,000 | +126.1% | 230,400 | +53.4% | 0.01% | +116.7% |
| Q3 2019 | $253,000 | -33.2% | 150,200 | -1.0% | 0.01% | -33.3% |
| Q2 2019 | $379,000 | -19.4% | 151,700 | -0.9% | 0.01% | 0.0% |
| Q1 2019 | $470,000 | +23.7% | 153,100 | +6.2% | 0.01% | +12.5% |
| Q4 2018 | $380,000 | -44.4% | 144,100 | -9.1% | 0.01% | -33.3% |
| Q3 2018 | $684,000 | +2.1% | 158,600 | -6.7% | 0.01% | 0.0% |
| Q2 2018 | $670,000 | +56.5% | 170,000 | -17.7% | 0.01% | +71.4% |
| Q1 2018 | $428,000 | +1.2% | 206,600 | +2.4% | 0.01% | 0.0% |
| Q4 2017 | $423,000 | -21.7% | 201,700 | 0.0% | 0.01% | -46.2% |
| Q3 2017 | $540,000 | +12.5% | 201,700 | +0.5% | 0.01% | +8.3% |
| Q2 2017 | $480,000 | – | 200,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|